Avacta Group PLC (AVCT)

Currency in GBP
74.94
-2.06(-2.68%)
Real-time Data·
AVCT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
74.0077.28
52 wk Range
26.0083.20
Key Statistics
Bid/Ask
74.00 / 76.00
Prev. Close
77
Open
77.28
Day's Range
74-77.28
52 wk Range
26-83.2
Volume
553.63K
Average Volume (3m)
2.78M
1-Year Change
57.14%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AVCT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
81.25
Upside
+8.42%
Members' Sentiments
Bearish
Bullish
ProTips
Stock price often moves in the opposite direction of the market

Avacta Group PLC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Avacta Group PLC Company Profile

Avacta Group Plc, together with its subsidiaries, engages in the development of cancer therapies in the United Kingdom, South Korea, and internationally. Its lead product candidate is AVA6000, a peptide drug conjugate form of doxorubicin, which is an approved cancer drug with known severe toxicities. The company is developing AVA6103, a peptide drug conjugate technology designed to deliver exatecan, a potent topoisomerase I inhibitor directly to tumors while limiting the exposure of the released exatecan in normal tissues; and AVA7100 that drives localization to fibroblast activation protein expressing tumors. The company was incorporated in 2003 and is headquartered in London, the United Kingdom.

Compare AVCT to Peers and Sector

Metrics to compare
AVCT
Peers
Sector
Relationship
P/E Ratio
−8.2x−6.7x−0.6x
PEG Ratio
0.12−0.110.00
Price/Book
2,317.7x0.8x2.6x
Price / LTM Sales
2,953.5x11.6x3.3x
Upside (Analyst Target)
11.0%134.5%43.6%
Fair Value Upside
Unlock−12.4%5.6%Unlock

Analyst Ratings

2 Buy
1 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 81.25
(+8.42% Upside)

Earnings

Latest Release
Sep 30, 2025
EPS / Forecast
-0.0423 / --
Revenue / Forecast
56.00K / --
EPS Revisions
Last 90 days

AVCT Income Statement

People Also Watch

329.61
CWR
+5.58%
0.036
ORCP
-5.26%
0.28
OBD
0.00%
350.71
HOCM
+0.37%
2,342.20
FRES
+2.28%

FAQ

What Stock Exchange Does Avacta Group Trade On?

Avacta Group is listed and trades on the London Stock Exchange stock exchange.

What Is the Stock Symbol for Avacta Group?

The stock symbol for Avacta Group is "AVCT."

What Is the Avacta Group Market Cap?

As of today, Avacta Group market cap is 324.21M.

What Is Avacta Group's Earnings Per Share (TTM)?

The Avacta Group EPS (TTM) is -0.11.

When Is the Next Avacta Group Earnings Date?

Avacta Group will release its next earnings report on 29 Sept 2025.

From a Technical Analysis Perspective, Is AVCT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Avacta Group Stock Split?

Avacta Group has split 1 times.

How Many Employees Does Avacta Group Have?

Avacta Group has 151 employees.

What is the current trading status of Avacta Group (AVCT)?

As of 24 Nov 2025, Avacta Group (AVCT) is trading at a price of 74.94, with a previous close of 77.00. The stock has fluctuated within a day range of 74.00 to 77.28, while its 52-week range spans from 26.00 to 83.20.

What Is Avacta Group (AVCT) Price Target According to Analysts?

The average 12-month price target for Avacta Group is GBP81.25, with a high estimate of GBP111 and a low estimate of GBP43. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +8.42% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.